January 2014

The 2nd annual forum on Optimizing Clinical Research Performance will be held on September 16-17, 2014 in Boston, MA USA. The conference intended to foster compelling and actionable conversations among senior-level, clinical research professionals from pharma, CROs, investigative sites and niche service providers.
 
The Israeli ministry of Health published a draft updated guideline for clinical trials in humans, and is calling to submit comments. The updated guideline can be found at the health ministry web site (Hebrew):
 
New in Israel: a center of information on clinical trials in humansThe website www.medical-research.co.il  is organizing in one place all information about clinical trials now taking place in Israel. The site was inspired by the American clinicaltrials.gov website ofthe FDA, the center of all the experiments conducted under the auspices of the Authority. (Hebrew)
 
JOHNSON AND JOHNSON TO OPEN MED-TECH INCUBATOR IN ISRAEL. Johnson and Johnson recently announced that it will be expanding its network of innovation centers, establishing a new center in Israel. The planned Israeli branch will operate as an incubator and will be located in Rehovot, near the Weizmann Institute. The initiative is the result of collaboration between J&J, Israel’s Chief Scientist’s Office, Japan’s Takeda Pharmaceuticals, and Israel’s OrbiMed. The company said that the new incubator “is the latest in a series of recently announced collaborations to fuel entrepreneurship in the world’s scientific hot spots.” 

U.S. FLAVORINGS GIANT IFF BUYS ISRAEL'S AROMOR FOR $88 MILLION. New York-based International Flavors & Fragrances (IFF) has acquired Israeli food flavorings maker Aromor of Kibbutz Givat Oz in the Lower Galilee. Terms of the deal were not disclosed, but analysts estimated that the company was sold for $88 million. The company is privately held, and half owned by the Kibbutz.  The company’s factory will remain at its present kibbutz location, located near Afula.
 
INDIA AND ISRAEL TO SET UP $40 MILLION FUND FOR JOINT VENTURESIndia and Israel recently announced plans to set up a $40 million fund to support joint technological ventures. The fund is designed to consolidate and strengthen economic ties between the two countries, with each country contributing $20 million to the fund over a period of five years. The fund will help Israeli companies participate in large Indian government-led ventures, will foster R&D collaboration between Israeli and Indian companies, and will further seek to adapt products developed in Israel for the Indian market, Israeli officials said.

10-YEAR STUDY: DRAMATIC INCREASES IN ISRAELI INVESTMENT RETURNS. The IVC Research Center recently released a comprehensive 10-year Israeli High-Tech Exits Report, compiled in collaboration with SiSense Ltd. The report suggests dramatic increases in venture capital-backed exits, in average deal size, and in average return-on-equity ratios. According to the report, VC-backed exits in Israel soared to $4.2 billion in 2013, a decade high. The average exit rose to $83 million, while the 2013 equity-return ratio reached an all time record of 5:3. The report comes amidst skyrocketing foreign direct investment in Israel in 2013.
 
LOCKHEED MARTIN AND EMC PARTNER FOR ADVANCED RESEARCH AND DEVELOPMENT IN ISRAEL Defense contractor Lockheed Martin and data storage equipment maker EMC Corporation announced plans to jointly invest in advanced technology projects at the Advanced Technologies Park in the southern Israeli city of Be’er-Sheva. The companies intend to develop partnerships with Israeli industry, government, and academic institutions to advance research and development projects in cloud computing, data analytics and cyber technologies. The companies expect the collaboration to result in the introduction of new technologies into their market portfolios.